Lilian Abbo Speaks at Infectious Disease Conference in London
Lilian Abbo, M.D., associate professor of clinical infectious diseases at the Miller School of Medicine and Chief of Infection Prevention and Antimicrobial Stewardship for Jackson Health System, was an invited speaker at the prestigious British Society of Antimicrobial Chemotherapy Spring Conference in London. The subject was “The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections.”
Gram negative bacteria are a group of bacteria that can cause infection and toxic reaction in patients, yet are difficult to differentiate and treat with antibiotics because of their structure. The proliferation of these infections is fueled by increased use of broad spectrum agents, and identification of successful treatment regimens has been challenged in recent years by the lack of new antibiotics available to treat them.
Successfully rising to the combined challenges of infection prevention, improved diagnostics and appropriate treatment is essential to reducing antibiotic resistance and improving patient outcomes. The title of Abbo’s presentation was “Current and New Treatments of Multidrug Resistant Gram Negative Infections: NDM, ESBL and KPC – the U.S. Experience.”
Abbo is also directing a free massive online learning course, “Challenges in Antibiotic Resistance: Gram Negative Bacteria,” for health care providers, trainees and students involved in the care of patients with infections. It will emphasize the importance of preventive measures to avoid the spread of antimicrobial resistance.
Registration for the course is available at https://www.futurelearn.com/courses/gram-negative-bacteria/1.
The course was developed by Abbo in collaboration with former UM/Jackson Memorial Hospital-trained infectious disease physicians Rossana Rosa and Jose Ramon Pano Pardo, with the support of the British Society of Antimicrobial Chemotherapy.